- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Tenzin Choden, MD, MS, is a board-certified gastroenterologist who diagnoses and treats digestive disorders that impact the intestines, liver, colon and more. Dr. Choden has advanced training in inflammatory bowel disease (IBD) and her practice primarily focuses on working closely with patients who are struggling with ulcerative colitis (UC), Crohn’s disease and checkpoint-inhibitor colitis. She provides compassionate care to each patient, developing customized treatment plans that are unique to her patient’s individual needs and healthcare goals. Dr. Choden uses novel medical therapies to treat inflammatory bowel disease and works with a multidisciplinary team of nutritionists, gastrointestinal psychologists and surgeons, as well as with the clinical trials division, to ensure the most up-to-date, comprehensive care.
In addition to her commitment to her patients, Dr. Choden is also invested in clinical research that involves clinical outcomes in IBD with new therapies and patient access to medications. Her work has been published in several highly respected, peer-reviewed journals, like Gastroenterology, Digestive Diseases and Sciences, Clinical Gastroenterology and Hepatology and Inflammatory Bowel Diseases.
Along with Dr. Choden’s devotion to patient care, she is also interested in mentoring residents and fellows, and serves on the Training Committee of the American College of Gastroenterology. She is actively engaged in teaching gastroenterology curriculum and providing in-depth training opportunities to help guide new physicians early in their medical career.
In addition to her commitment to her patients, Dr. Choden is also invested in clinical research that involves clinical outcomes in IBD with new therapies and patient access to medications. Her work has been published in several highly respected, peer-reviewed journals, like Gastroenterology, Digestive Diseases and Sciences, Clinical Gastroenterology and Hepatology and Inflammatory Bowel Diseases.
Along with Dr. Choden’s devotion to patient care, she is also interested in mentoring residents and fellows, and serves on the Training Committee of the American College of Gastroenterology. She is actively engaged in teaching gastroenterology curriculum and providing in-depth training opportunities to help guide new physicians early in their medical career.
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Internal Medicine
- Gastroenterology
Practicing Since
- 2015
Languages Spoken
- English
- Hindi
- Tibetan
Medical Education
- Eastern Virginia Medical School
Internship
- Medstar Georgetown University Hospital
Residency
- MedStar Georgetown University Hospital
Fellowship
- MedStar Georgetown University Hospital; University of Chicago
Memberships & Medical Societies
- American College of Gastroenterology
- American Gastroenterological Association
- Crohn's and Colitis Foundation
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.